Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Benzoic acid and its sodium salt is listed in Annex V of the EU Cosmetics Regulation (EC) 1223/2009 (preservatives allowed in cosmetic products).
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 25/100 (minor) · high confidence.
Prevalence of SODIUM BENZOATE in our catalog (epa_cpdat).
Products
8,863
Brands
6
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside SODIUM BENZOATE in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
EU
EC
Annex V of EU Cosmetics Regulation (EC) 1223/2009: preservatives allowed in cosmetic products. Product types: a) Rinse-off products, except oral care products b) Oral care products c) Leave-on products Maximum concentration: a) 2.5% (acid) b) 1.7% (acid) c) 0.5% (acid)
US
EPA
EPA CPDat observed this chemical in 8863 composition records across product categories including Home maintenance, Laboratory supplies, Industrial products. EPA CPDat classifies this chemical for functional uses including Preservative, Corrosion inhibitor, Biocide.
US
Champoings
Pantene
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
FDA
Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 1 mg
US
FDA
Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 3 mg
US
FDA
Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 0.5 %w/w
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 864 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Potency: 4.8 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 864 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: 0.1 %w/v
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: ELIXIR; Potency: 5.02 mg/5ml
US
FDA
Route: ORAL; Dosage form: GRANULE, EFFERVESCENT; Potency: 60 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 61 mg
US
FDA
Route: ORAL; Dosage form: PASTE; Maximum daily exposure: 28 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 98 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 160 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 660 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 320 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 23 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 80 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 0.34 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 1 mg
US
FDA
Route: RECTAL; Dosage form: ENEMA; Maximum daily exposure: 60 mg
US
FDA
Route: RECTAL; Dosage form: GEL; Maximum daily exposure: 406 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 5 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.1 %w/v
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 2 mg
US
FDA
FDA NDC lists this ingredient in 13 active drug products and 17 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.